HGF and breast carcinoma: The SLIT2/ROBO1 pathway inhibits cell invasion by interacting with E-cadherin and β-catenin in breast cancer and colorectal cancer [41,42,43], whereas in liver cancer, SLIT2/ROBO1 specifically inhibits hepatocyte growth factor (HGF)–mediated cell migration [42].